By concentrating on keratinocyte turnover, another useful atopic dermatitis model was developed: epidermis-restricted ablation of the proto-oncogene BRAF/RAF1 led to barrier defects and local and systemic IgE and Th2 inflammation; Janus kinase inhibition prevented disease onset [22]. This evidence concerns the gene IGHE and atopic eczema.